Psychotic depression

Psychotic Depression

Volumn , Issue , 2007, Pages 1-327

  Swartz, Conrad M ^a   Shorter, Edward ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929746159     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511547201     Document Type: Book

References (417)

1. Aarsland, D., Larsen, J. P., Cummings, J. L., and Laake, K. 1999. Prevalence and clinical correlates of psychotic symptoms in Parkinson Disease. A community-based study. Arch Neurol 56: 595-601.
2. Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.
3. Abrams, R. and Taylor, M.A. 1983. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 5: 179-81.
4. Alexopoulos, G. S., Meyers, B.S., Young, R. C., et al. 1993. The course of geriatric depression with “reversible dementia”: A controlled study. Am J Psychiatry 150: 1693-9.
5. American Psychiatric Association (APA) 1994. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA, pp. 348-384, 6.
6. Amsterdam, J. D. and Shults, J. 2005. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: A double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 20: 257-64.
7. Andreassen, O. A., Ferrante, R. J., Aamo, T. O., et al. 2003. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122: 717-25.
8. Angst, F., Stassen, H. H., Clayton, P.J., and Angst, J. 2002. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 68: 167-81.
9. Anton, R. F., Jr. and Burch, E.A., Jr. 1990. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 147: 1203-8.
10. Anton, R. F., Jr. and Burch, E. A., Jr. 1993. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord 28: 125-31.
11. Aronson, T. A., Shukla, S., and Hoff, A. 1987. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251-9.
12. Aronson, T. A., Shukla, S., Hoff, A., and Cook, B. 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69-74
13. Arroll, B., Macgillivray, S., Ogston, S., et al. 2005. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis. Ann Family Med 3: 449-56.
14. Associated Press. 2006. Woman not guilty in retrial in the deaths of her 5 children. New York Times, July 27, p. A18.
15. Avery, D. and Lubrano, A. 1979. Depression treated with imipramine and ECT: The DeCarolis study reconsidered. Am J Psychiatry 136: 559-62.
16. Avery, D. and Winokur, G. 1976. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029-37.
17. Bakish, D. 2001. New standard of depression treatment: Remission and full recovery. J Clin Psychiatry 62(Suppl 26): 5-9.
18. Banken, R. 2002. The use of electroconvulsive therapy in Quebec. Agence d'valuation des technologies et des modes d'intervention en sant (AETMIS). Montreal: AETMIS.
19. Bassett, S. S. 2005. Cognitive impairment in Parkinson's Disease. Prim Psychiatry 12: 50-55.
20. Bayley, J. 1881. Case of recurrent melancholia. Lancet 2: 1041-2.
21. Beck, A. T. 1967. Depression: Clinical, experimental, and theoretical aspects. New York: Harper & Row.
22. Belanoff, J. K., Rothschild, A. J., Cassidy, F., et al. 2002. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386-92.
23. Bellini, L., Gatti, F., Gasperini, M., and Smeraldi, E. 1992. A comparison between delusional and non-delusional depressives. J Affect Disord 25: 129-38.
24. Benziger, B.F. 1969. The prison of my mind. New York: Walker.
25. Bergemann, N., Frick, A., Parzer, P., and Kopitz, J. 2004. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry 37: 63-8.
26. Birkenhager, T. K. and Moleman, P. 1999. Two new antidepressants: Mirtazapine and venlafaxine. Ned Tijdscr Geneeskd 143: 934-7.
27. Birkenhager, T. K., Pluijms, E. M., and Lucius, S.A. 2003. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 74: 191-5.
28. Black, D. W. and Winokur, G. 1989. Psychotic and nonpsychotic depression: Comparison of response to ECT. J Clin Psychiatry 50: 186.
29. Bonomo, V. and Fogliani, A. M. 2000. Citalopram and haloperidol for psychotic depression. Am J Psychiatry 157: 1706-7.
30. Bowers, M. B. and Swigar, M. E. 1988. Psychotic patients who become worse on neuroleptics. J Clin Psychopharmacol 8: 417-21.
31. Bremner, J. D., Vythinlingam, M., Ng, C. K., et al. 2003. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289: 3125-34.
32. Breslau, N. and Meltzer, H.Y. 1988. Validity of subtyping psychotic depression: Examination of phenomenology and demographic characteristics. Am J Psychiatry 145: 35-40.
33. Brockington, I. F., Roper, A., Copas, J., et al. 1991. Schizophrenia, bipolar disorder and depression. A discriminant analysis, using “lifetime” psychopathology ratings. Br J Psychiatry 159: 485-94.
34. Brown, G.W., Ni Bhrolchain, M., and Harris, T. O. 1979. Psychotic and neurotic depression. Part 3. Aetiological and background factors. J Affect Disord 1: 195-211.
35. Brown, R. P., Frances, A., Kocsis, J.H., and Mann, J.J. 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635-7
36. Brown, T. A., Campbell, L. A., Lehman, C. L., et al. 2001. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 110: 585-99.
37. Brujin, J.A., Moleman, P., Mulder, P.G., et al. 1996. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacol (Berlin) 237: 231-7.
38. Burch, E.A. and Goldschmidt, T.J. 1983. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. South Med J 76: 991-5.
39. Cade, J. F. J. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349-52.
40. Calabrese, J. R., Keck, P. B., MacFadden, W., et al. 2005. A randomized double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162: 1351-60.
41. Carpenter, W. T. and Buchanan, R. W. 1994. Schizophrenia. N Engl J Med 330: 681-90.
42. Carroll, B. J. 1981. Review of Harold I. Kaplan, et al. (eds) Comprehensive textbook of psychiatry, 3rd edn. Am J Psychiatry 138: 705-7.
43. Carroll, B. J. 1982. The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292-304.
44. Carroll, B. J. 1983. Neurobiologic dimensions of depression and mania. In Jules Angst (ed.) The origins of depression: Current concepts and approaches. Berlin: Springer.
45. Carroll, B. J., Curtis, G. C., and Mendels, J. 1976. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6: 235-44.
46. Carroll, B. T., Thomas, C., Jayanti, K., et al. 2005. Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry 4: 56-64.
47. Casey, D. A. 1987. Electroconvulsive therapy in the neuroleptic malignant syndrome. Convuls Ther 3: 278-83.
48. Cerletti, U. 1940. L'Elettroshock. Rivista Sperimentale di Freniatria 64: 209-310.
49. Chan, C. H., Janicak, P. G., Davis, J. M., et al. 1987. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48: 197-200.
50. Chelminski, I., Zimmerman, M., and Mattia, J. I. 2000. Diagnosing melancholia. J Clin Psychiatry 61: 874-5.
51. Chouinard, G. and Steinberg, S. 1984. New clinical concepts on neuroleptic-induced supersensitivity disorders: Tardive dyskinesia and supersensitivity psychosis. In H. C. Stancer, P. E. Garfinkel, and V. M. Rakoff (eds) Guidelines for the use of psychotropic drugs. New York: Spectrum, pp. 205-27.
52. Corcept Therapeutics, Inc. 2006. Corcept Therapeutics announces negative results from the first of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression. PR Newswire, August 25, accessed September 13, 2006 at http://biz.yahoo.com/prnews/060825/laf0i8.html?.v=6i
53. Cotard, J. 1880. Du delire des negations. Archives de neurologie 4: 152-70.
54. Coryell, W. and Tsuang, M. T. 1982. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 39: 1181-4 Cambridge Books Online Cambridge University Press, 2009
55. Coryell, W., Pfohl, B., and Zimmerman, M. 1984. The clinical and neuroendocrine features of pscyhotic depression. J Nerv Ment Dis 172: 521-8.
56. Coryell, W., Zimmerman, M., and Pfohl, B. 1986. Outcome at discharge and six months in major depression. The significance of psychotic features. J Nerv Ment Dis 174: 92-6
57. Cullen, M., Mitchell, P., Brodaty, H., et al. 1991. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 52: 472-6.
58. Davidson, J., McLeod, M., Law-Yone, B., and Linnoila, M. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639-42.
59. DeBattista, C., Belanoff, J., Glass, S., et al. 2006. Mifeprisone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60: 1343-9.
60. De Montigny, C., Grunberg, F., Mayer, A., et al. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252-6.
61. DelBello, M. P., Carlson, G. A., Tohen, M., et al. 2003. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolesc Psychopharmacol 13: 173-85.
62. Denber, H.C. B. 1957. Treatment of chlorpromazine-diethazine in depression. Dis Nerv Syst 17: 76-9.
63. Denno, D. W. 2003. Who is Andrea Yates? A short story about insanity. Duke J Gend Law Policy 10: 1-139.
64. Dietrich, D.E., Godecke-Koch, T., Richter-Witte, C., and Emrich, H. M. 2004. Lamotrigine in the treatment of confusion psychosis, a case report. Pharmacopsychiatry 37: 88-90.
65. Donlon, P. T., Biertuemphel, H., and Willenbring, M. 1981. Amoxapine and amitriptyline in the outpatient treatment of endogenous depression. J Clin Psychiatry 42: 11-15.
66. Downs, J. M., Akiskal, H. G., and Rosenthal, T. L. 1993. Neuroleptic-induced pseudoschizoaffective disorder (abstract 146). Proc Am Psychiatric Assoc Annual Meet, p. 153 (full program on audiotape).
67. Dubovsky, S.L. and Thomas, M. 1992. Psychotic depression: Advances in conceptualization and treatment. Hosp Comm Psychiatry 43: 1189-98.
68. Eagles, J. M. 1983. Delusional depressive in-patients, 1892-1982. Br J Psychiatry 143: 558-63.
69. Erfurth, A., Walden, J., and Grunze, H. 1998. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38: 204-5.
70. Ernst K. 1983. Geisteskrankheit ohne institution: Eine feldstudie im Kanton Fribourg aus dem jahr 1875. Schweizer Archiv fur Neurologic, Neurochirurgie und Psychiatric 133: 239-62.
71. Evans, D. L. and Nemeroff, C.B. 1987. The clinical use of the Dexamethasone Suppression Test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatr Res 21: 185-194.
72. Feighner, J. P., Robins, E., Guze, S. B., et al. 1972. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57-63.
73. Fenichel, O. 1945. The psychoanalytic theory of neurosis. New York: Norton.
74. Fink, M. 1979. A theory of convulsive therapy (chapter 14). In M. Fink (ed.) Convulsive therapy: Theory and practice. New York: Raven Press, p. 173.
75. Fink, M. and Taylor, M.A. 2003. Catatonia: A clinician's guide to diagnosis and treatment. New York: Cambridge University Press.
76. Fink, M., Klein, D. F., and Kramer, J. C. 1965. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 7: 27-36.
77. Finlay-Jones, R. and Parker, G. 1993. A consensus conference on psychotic depression. Aust NZ J Psychiatry 27: 581-9.
78. Fish, F. 1964. Concluding observations. In E. Beresford Davies (ed.) Depression: Proceedings of the symposium held at Cambridge 22 to 26 September 1959. Cambridge, UK: Cambridge University Press, pp. 349-52.
79. Flint, A.J. and Rifat, S.L. 1998a. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23-8.
80. Flint, A.J. and Rifat, S. L. 1998b. Two-year outcome of psychotic depression in late life. Am J Psychiatry 155: 178-83.
81. Flor-Henry, P. 1983. Determinants of psychosis in epilepsy, laterality and forced normalization. Biol Psychiatry 18: 1045-57.
82. Freud, S. 1946. Trauer und melancholie (1916). In Freud (ed.) Gesammelte Werke, vol. 10. Frankfurt: M. Fischer, pp. 428-46.
83. Freyhan, F.A. 1959. Clinical effectiveness of tofranil in the treatment of depressive psychoses. Can Psychiatr Assoc J 4(Suppl): S86-S97.
84. Freyhan, F.A. 1961. The influence of specific and non-specific factors on the clinical effects of psychotropic drugs. Neuropsychopharmacology 2: 189-203.
85. Fricchione, G. L., Cassem, N.H., and Hooberman, D. 1983. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 3: 338-42.
86. Fritsch, J. 1882. Diagnostik und therapie der melancholischen krankheits-formen. Zeitschrift fur Diagnostik und Therapie 1: 101-3.
87. Frueh, B.C., Knapp, R. G., Cusack, K.J., et al. 2005. Patients' reports of traumatic or harmful experience within the psychiatric setting. Psychiatric Serv 56: 1123-33.
88. Gatti, F., Bellini, L., Gasperini, M., et al. 1996. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 153: 414-6.
89. Gaupp, R. 1926. Krankheitseinheit und mischpsychosen. Zeitschrift fur die gesamte Neurologie und Psychiatrie 101: 1-15.
90. Ghaemi, S.N., Lenox, M.S., and Baldessarini, R.J. 2001. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62: 565-9.
91. Gillespie, R. D. 1926. Discussion comment. BMJ 2: 878.
92. Gimsa, U., Schreiber, U., Habel, B., et al. 2006. Matching geometry and stimulation parameters of electrodes for deep brain stimulation experiments-numerical considerations. J Neurosci Meth 150: 212-27.
93. Glassman, A. H. and Roose, S.P. 1981. Delusional depression: A distinct clinical entity? Arch Gen Psychiatry 38: 424-7.
94. Glassman, A. H., Kantor, S. J., and Shostak, M. 1975. Depression, delusions, and drug response. Am J Psychiatry 132: 716-19.
95. Glick, I.D., Murray, S.R., Vasudevan, P., et al. 2001. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 35: 187-91.
96. Goldman, D. 1955. The effect of chlorpromazine on severe mental and emotional disturbances. In Chlorpromazine and mental health: Proceedings of the symposium held under the auspices of Smith, Kline & French Laboratories, June 6, 1955. Philadelphia: Lea & Febiger, pp. 19-40.
97. Goodwin, F. K., Prange, A. J., Post, R. M., Muscettola, G., and Lipton, M. A. 1982. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry 139: 34-8.
98. Goren, J. L. and Levin, G. M. 2000. Mania with bupropion: A dose-related phenomenon? Ann Pharmacother 34: 619-21.
99. Gournellis, R., Lykouras, L., Fortos, A., et al. 2001. Psychotic (delusional) major depression in late life: A clinical study. Int J Geriatr Psychiatry 16: 1085-91.
100. Grunhaus, L., Dannon, P. N., Schreiber, S., et al. 2000. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study. Biol Psychiatry 47: 314-24.
101. Grunze, H., Marcuse, A., Scharer, L. O., et al. 2002. Nefazodone in psychotic unipolar and bipolar depression: A retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol. Neuropsychobiology 46(Suppl 1): 31-5.
102. Guze, S.B., Woodruff, R.A., Jr, and Clayton, P.J. 1975. The significance of psychotic affective disorders. Arch Gen Psychiatry 32: 1147-50.
103. Hamilton, M. 1989. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201-6.
104. Hermann, R. C., Dorwart, R.A., Hoover, C. W., and Brody, J. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869-75.
105. Hill, S.K., Keshavan, M.S., Thase, M.E., and Sweeney, J.A. 2004. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry 161: 996-1003.
106. Hippius, H. and Jantz, H. 1959. Die heutige behandlung der depressionen. Nervenarzt 30: 466-73.
107. Hoch, A. and MacCurdy, J. T. 1922 The prognosis of involution melancholia. Arch Neurol Psychiatry 7: 1-37.
108. Hodgkiss, A. D., Malizia, A. L., Bartlett, J. R., and Bridges, P. K. 1995. Outcome after the psychosurgical operation of stereotactic subcaudate tractotomy, 1979-1991. J Neuropsychiatry Clin Neurosci 7: 230-4.
109. Hoff, H. 1959. Indications for electro-shock, tofranil and psychotherapy in the treatment of depressions. Can Psychiatr Assoc J 4(Suppl): S55-S68.
110. Hollister, L. E. and Overall, J. E. 1965. Reflections on the specificity of action of anti-depressants. Psychosomatics 6: 361-5.
111. Honore, P., Moller, S. E., and Jorgensen, A. 1982. Lithium + l-tryptophan compared with amitriptyline in endogenous depression. J Affect Disord 4: 79-82.
112. Hordern, A., Holt, N. F., Burt, C. G., and Gordon, W. F. 1963. Amitriptyline in depressive states: Phenomenology and prognostic considerations. Br J Psychiatry 10: 815-25.
113. Jager, M., Bottlender, R., Strauss, A., and Moller, H.J. 2005. Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: The prognostic significance of psychotic features. Compr Psychiatry 46: 322-7.
114. Jain, V. and Swartz, C. M. 2002. Charcoal enhancement of treatment for tricyclic-induced mania. Pharmacopsychiatry 35: 197-9.
115. Janicak, P. G., Pandey, G. N., Davis, J. M., et al. 1988. Response of psychotic and nonpsychotic depression to phenelzine. Am J Psychiatry 145: 93-5.
116. Jaspers, K. 1913. Allgemeine psychopathologie. Berlin: Springer.
117. Jeste, D.V., Heaton, S.C., Paulsen, J. S., et al. 1996. Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. Am J Psychiatry 153: 490-6.
118. Joffe, R. T., MacQueen, G. M., Marriott, M., et al. 2002. Induction of mania and cycle acceleration in bipolar disorder: Effect of different classes of antidepressant. Acta Psychiatr Scand 105: 427-30.
119. Johnson, J., Horwath, E., and Weissman, M. M. 1991. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 48: 1075-81.
120. Joseph, K. S., Blais, L., Ernst, P., and Suissa, S. 1996. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 312(7023): 79-82.
121. Judd, L. L., Akiskal, H. S., Schettler, P. J., et al. 2002. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59: 530-7.
122. Judd, L. L., Paulus, M.J., Schettler, P.J., et al. 2000. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157: 1501-4.
123. Kahlbaum, K. 1863. Die Gruppirung der Psychischen Krankheiten und die Eintheilung der Seelenstorungen. Danzig: Kafemann.
124. Kalinowsky, L. B. 1941. The various forms of shock therapy in mental disorders and their practical importance. NY State J Med 41: 2210-15.
125. Kantor, S.J. and Glassman, A. H. 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351-60.
126. Kellner, C. H., Fink, M., Knapp, R., et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977-82.
127. Kendell, R. E., Chalmers, J. C., and Platz, C. 1987. Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662-73.
128. Kielholz, P. 1954. Uber die largactilwirkung bei depressiven zustanden und manien sowie bei der entziehung von morphin-und barbitursuchtigen. Schweizer Archiv fur Neurologie und Psychiatrie 73: 291-309.
129. Kiloh, L. G. and Garside, R. F. 1963. The independence of neurotic depression and endogenous depression. Br J Psychiatry 109: 451-63.
130. Kiloh, L. G. and Garside, R. F. 1977. Depression: A multivariate study of Sir Aubrey Lewis's data on melancholia. Aust NZ J Psychiatry 11: 149-56.
131. Kinross-Wright, V. 1955. Chlorpromazine treatment of mental disorders. Am J Psychiatry 111: 907-12.
132. Kirk, S. A. and Kutchins, H. 1992. The selling ofDSM: The rhetoric of science in psychiatry. New York: Aldine.
133. Kiser, S. 2004. An existential case study of madness: Encounters with divine affliction. J Human Psychol 44: 431-54.
134. Kivela, S. L. and Pahkala, K. 1989. Delusional depression in the elderly: A community study. Zeitschrift fur Gerontologie 22: 236-41.
135. Klein, D. and Fink, M. 1962. Behavioral reaction patterns with phenothiazines. Arch Gen Psychiatry 7: 449-59.
136. Klein, D. F. 1976. Differential diagnosis and treatment of the dysphorias. In Donald M. Gallant (ed.) Depression: Behavioral, biochemical, diagnostic and treatment concepts. New York: Spectrum, pp. 127-54.
137. Klerman G. L. 1974. Unipolar and bipolar depressions. In Jules Angst (ed.) Classification and prediction of outcome of depression. Stuttgart: F. K. Schattauer, pp. 49-74.
138. Klerman, G. L. and Cole, J. O. 1965. Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17: 101-41.
139. Kocsis, J. H., Croughan, J. L., Katz, M. M., et al. 1990. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. Am J Psychiatry 147: 621-4.
140. Kostiukova, E. G. 1989. Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses. Zhurnal Nevropatologii I Psikhiatrii Imeni S-S-Korsakova 89: 64-71.
141. Kraepelin, E. 1913. Psychiatrie: Ein lehrbuch fur studierende und aerzte, 8th edn, vol. 3(2). Leipzig: Barth; 6th edn, 1899.
142. Kramer, B.A. 1999. Use of ECT in California, revised: 1984-1994. JECT15: 245-51.
143. Kranz, H. 1955. Das thema des wahns im wandel der zeit. Fortschritte der Neurologie und Psychiatrie 23: 58-72.
144. Kreye, A. 2005. Hausfrauenreport aus Hollywood. Sueddeutsche Zeitung, April 9, p. 22.
145. Kroessler, D. 1985. Relative efficacy rates for therapies of delusional depression. Convuls Ther 1: 173-82.
146. Kuhs, H. 1991. Depressive delusion. Psychopathology 24: 106-14.
147. La Rue, A., Spar, J., and Hill, C. D. 1986. Cognitive impairment in late-life depression: Clinical correlates and treatment implications. J Affect Disord 11: 179-84
148. Lambert, M. V. and Robertson, M. M. 1999. Depression in epilepsy: Etiology, phenomenology, and treatment. Epilepsia 40(Suppl 10): S21-S47.
149. Lancet, 1940. Editorial: Primum non nocere. Lancet 1: 275.
150. Lee, P. E., Sykora, K., Gill, S.S., et al. 2005. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: A population-based cohort study in older adults. J Am Geriatr Soc 53: 1374-9.
151. Lenz, H. 1967. Themenwandel in der psychopathologie. Wiener Zeitschriftfur Nervenheilkunde 25: 286-96.
152. Leonhard, K. 1957. Aufteilung der endogenen Psychosen. Berlin: Akademie-Verlag, pp. 185-217.
153. Lesser, I. M., Miller, B. L., Boone, K. B., et al. 1991. Brain injury and cognitive function in late-onset psychotic depression. J Neuropsychiatry Clin Neurosci 3: 33-40.
154. Lesser, I.M., Rubin, R. T., Rifkin, A., et al. 1989. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord 16: 49-58.
155. Lew, T. Y. and Tollefson, G. 1983. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry 18: 1441-6.
156. Lewis, A. 1971. ''Endogenous'' and ''exogenous'': A useful dichotomy? Psychol Med 1: 191-6.
157. Lewis, A.J. 1934. Melancholia: A clinical survey of depressive states. J Ment Sci 80: 277-378.
158. Lewis, D. A. and Smith, R. E. 1983. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5: 319-32.
159. Lieberman, J.A., Stroup, T. S., McEvoy, J.P., et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 242: 1209-23.
160. Liu, Z. X. and Wang, D. C. 1992. A clinical and follow-up study in 33 cases of rapid cyclic affective psychosis. Zhonghua Shen Jing Jing Shen Ke Za Zhi 25: 341-350
161. Lu, M.L., Pan, J.J., Teng, H. W., et al. 2002. Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother 36: 1387-90.
162. Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986a. Delusional depression: Phenomenology and response to treatment. Psychopathology 19: 157-64.
163. Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986b. Delusional depression: Phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324-9.
164. Maj, M., Pirozzi, R., and Di Caprio, E. L. 1990. Major depression with mood-congruent psychotic features: A distinct diagnostic entity or a more severe subtype of depression? Acta Psychiatr Scand 82: 439-44.
165. Malla, A. K., Norman, R. M., Manchanda, R., et al. 2002. One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophr Res 54: 231-42.
166. Margolese, H. C., Chouinard, G., Beauclair, L., and Belanger, M. C. 2002. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 22: 347-52.
167. Markowitz, J., Brown, R., Sweeney, J., and Mann, J. J. 1987. Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 144: 1025-9.
168. Marsh, L., Williams, J. R., Rocco, M., et al. 2004. Psychiatric comorbidities associated with psychosis in patients with Parkinson's disease. Neurology 63: 293-300.
169. Marshall, M., Lewis, S., Lockwood, A., et al. 2005. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62: 975-83.
170. Martin, J. L., Barbanoj, M.J., Schlaepfer, T. E., et al. 2002. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2: CD003493.
171. Mason, B.J., Kocsis, J. H., Frances, A. J., and Mann, J.J. 1990. Amoxapine versus amitriptyline for continuation therapy of depression. J Clin Psychopharmacol 10: 338-43.
172. Masters, K. M. and Wandless, D. 2005. Use of pulse oximetry during restraint episodes. Psychiatr Serv 56: 1313-14.
173. Maudsley, H. 1867. The physiology and pathology of mind. New York: Appleton.
174. Mayberg, H. S., Lozano, A. M., Voon, V., et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651-60.
175. McDonald, C., Bullmore, E., Sham, P., et al. 2005. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder. Br J Psychiatry 18: 369-77.
176. McGrath, P. I., Stewart, J.W., Nunes, E.N., and Quitkin, F.M. 1994. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. J Clin Psychiatry 55: 336-9.
177. McIntyre, R., Mancini, D.A., McCann, S., et al. 2002. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disord, 4: 207-213.
178. Meyer, J.H., Kruger, S., Wilson, A. A., et al. 2001. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12: 4121-5.
179. Meyers, B.S., Klimstra, S.A., Gabriele, M., et al. 2001. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 9: 415-22.
180. Mingazzini, G. 1926. Die modifikationen der klinischen symptome, die einige psychosen in den letzten jahrzehnten erfahren haben. Psychiatrisch-Neurologische Wochenschrift 28: 68-72.
181. Mirza, N. R., Bright, J. L., Stanhope, K.J., et al. 2005. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: A potential role for sodium channels? Psychopharmacol (Berlin) 180: 159-68.
182. Mueser, K. T., Goodman, L. B., Trumbetta, S.L., et al. 1998. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 66: 493-9.
183. Muller-Siecheneder, F., Muller, M.J., Hillert, A., et al. 1998. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 18: 111-20.
184. Mulsant, B. H., Haskett, R. F., Prudic, J., et al. 1997. Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 154: 559-61.
185. Mulsant, B.H., Sweet, R. A., Rosen, J., et al. 2001. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 62: 597-604.
186. Munro, T. A. 1949. On depression. Edinburgh Med J 56: 530-43.
187. Musa, M.N. and Tripuraneni, B.R. 1993. Lithium-induced polyuria ameliorated by potassium supplementation. Lithium 4: 199-203.
188. Myers, B. S. and Greenberg, R. 1986. Late-life delusional depression. J Affect Disord 11: 133-7.
189. Naidu, P. S. and Kulkarni, S. K. 2001. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide. Behav Pharmacol 12: 209-16.
190. Naimark, D., Jackson, E., Rockwell, E., and Jeste, D.V. 1996. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc 44: 96-9.
191. Navarro, V., Gasto, C., Torres, X., et al. 2001. Citalopram versus nortriptyline in late-life depression: A 12-week randomized single-blind study. Acta Psychiatr Scand 103: 435-40.
192. Nelson, J. C. and Bowers, M. B., Jr. 1978. Delusional unipolar depression: Description and drug response. Arch Gen Psychiatry 35: 1321-8.
193. Nelson, J. C. and Charney, D. S. 1981. The symptoms of major depressive illness. Am J Psychiatry 138: 1-13.
194. Nelson, J. C. and Mazure, C. M. 1986. Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 143: 363-6.
195. Nelson, J. C., Charney, D.S., and Quinlan, D.M. 1981. Evaluation of the DSM-III criteria for melancholia. Arch Gen Psychiatry 38: 555-9.
196. Nelson, J. C., Price, L. H., Jatlow, P. I. 1986. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. Am J Psychiatry 143: 1151-4.
197. Nelson, L. A. and Swartz, C. M. 2000. Melancholic symptoms from concurrent olanzapine and fluoxetine. Ann Clin Psychiatry 12: 167-70.
198. Niskanen, P. and Achte, K. A. 1972. Disease pictures of depressives psychoses in the decades 1880-89, 1900-09, 1930-39, and 1960-69. Psychiatria Fennica 95-100.
199. Olfson, M., Marcus, S., Sackeim, H.A., Thompson, J., and Pincus, H.A. 1998. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry 155: 2-29.
200. Overall, J. E., Hollister, L. E., Johnson, M., and Pennington, V. 1966. Nosology of depression and differential response to drugs. JAMA 195: 946-8.
201. Overall, J.E., Hollister, L. E., Pokorny, A. D., et al. 1962. Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazide, dextroamphetamine-amobarbital, and placebo. Clin Pharmacol Ther 3: 16-22.
202. Pai, M., White, A. C., and Deane, A. G. 1986. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 148: 736-8.
203. Papakostas, G. I., Alpert, J. E., and Fava, M. 2003. S-adenosyl-methionine in depression: A comprehensive review of the literature. Curr Psychiatry Rep 5: 460-6.
204. Pare, C. M., Kline, N., Hallstrom, C., and Cooper, T. B. 1982. Will amitriptyline prevent the ''cheese'' reaction of monoamine oxidase inhibitors? Lancet 2(8291): 183-6.
205. Parker, G. 2000. Classifying depression: Should paradigms lost be regained? Am J Psychiatry 157: 1195-203.
206. Parker, G. 2004. Evaluating treatments for the mood disorders: Time for the evidence to get real. Aust NZ J Psychiatry 38: 408-14.
207. Parker, G., Hadzi-Pavlovic, D., Brodaty, H., et al. 1995. Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med 25: 825-32.
208. Parker, G., Hadzi-Pavlovic, D., Hickie, I., et al. 1991a. Distinguishing psychotic and non-psychotic melancholia. J Affect Disord 22: 135-48.
209. Parker, G., Hadzi-Pavlovic, D., Hickie, I., et al. 1991b. Psychotic depression: A review and clinical experience. Aust NZ J Psychiatry 25: 169-80.
210. Parker, G., Roussos, J., Mitchell, P., et al. 1997. Distinguishing psychotic depression from melancholia. J Affect Disord 42: 155-67.
211. Parker, G., Roy, K., Hadzi-Pavlovic, D., and Pedic, F. 1992. Psychotic (delusional) depression: A meta-analysis of physical treatments. J Affect Disord 24: 17-24.
212. Parvin, M. M., Swartz, C. M., and LaMontagne, B. 2004. Patient education by ECT experienced volunteer. J ECT 20: 127-9.
213. Perry, P. J., Morgan, D. E., Smith, R. E., and Tsuang, M. T. 1982. Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant-antipsychotic combinations. J Affect Disord 4: 195-200.
214. Petrides, G., Fink, M., Husain, M. M., et al. 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. J ECT17: 44-53.
215. Piasecki, S.D. and Jefferson, J.W. 2004. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry 65: 845-9.
216. Placidi, G. F., Lenzi, A., Lzzerini, F., et al. 1986. The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 47: 490-4.
217. Plath, S. 1996. The bell jar (1971), 25th anniversary edn. New York: HarperCollins.
218. Pollak, P., Tison, F., Rascol, O., et al. 2004. Clozapine in drug induced psychosis in Parkinson's disease: A randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 75: 689-95.
219. Pope, H. G. and Katz, D. L. 1994. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51: 375-82.
220. Popli, A. P., Fuller, M.A., and Jaskiw, G. E. 1997. Sertraline and psychotic symptoms: A case series. Ann Clin Psychiatry 9: 15-17.
221. Price, J. P. 1978. Chronic depressive illness. BMJ 1: 1200-1.
222. Price, L. H., Conwell, Y., and Nelson, J. C. 1983. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140: 318-22.
223. Prien, R. F., Kupfer, D.J., Mansky, P.A., et al. 1984. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41: 1096-104.
224. Quitkin, F., Klein, D.F., and Rifkin, A. 1978. Imipramine response in deluded depressive patients. Am J Psychiatry 7: 806-11
225. Rabheru, K. and Persad, E. 1997. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476-84.
226. Rabiner, E. A., Bhagwagar, Z., Gunn, R. N., et al. 2001. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry 158: 2080-2.
227. Raja, M. and Azzoni, A. 2003. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. Int J Neuropsychopharmacol 6: 409-14.
228. Ranjan, R. and Meltzer, H.Y. 1996. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 40: 253-8.
229. Rapaport, M. H., Judd, L. L., Schettler, P.J., et al. 2002. A descriptive analysis of minor depression. Am J Psychiatry 159: 637-43.
230. Ries, R. and Bokan, J. 1979. Electroconvulsive therapy following pituitary surgery. J Nerv Ment Dis 167: 767-8.
231. Robinson, A. D. T. 1988. A century of delusions in south west Scotland. Br J Psychiatry 153: 163-7.
232. Roose, S. P., Glassman, A. H., Walsh, B.T., et al. 1983. Depression, delusions, and suicide. Am J Psychiatry 140: 1159-62.
233. Roose, S. P., Sackeim, H.A., Krisnan, K. R. R., et al. 2004. Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 161: 2050-9.
234. Ropacki, S. A. and Jeste, D. V. 2005. Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 162: 2022-30.
235. Rothschild, A.J. and Duval, S.E. 2003. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry 64: 390-6.
236. Rothschild, A. J. and Phillips, K. A. 1999. Selective serotonin inhibitors and delusional depression. Am J Psychiatry 156: 977-8.
237. Rothschild, A.J., Samson, J.A., Bessette, M. P., et al. 1993. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 54: 338-42.
238. Rothschild, A.J., Williamson, D.J., Tohen, M.F., et al. 2004. A doubleblind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 24: 365-73.
239. Rush, A.J., Marangell, L. B., Sackeim, H.A., et al. 2005. Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry 58: 347-54.
240. Ruskin, D.B. and Goldner, R. 1959. Treatment of depressions in private practice with imipramine. Dis Nerv Syst 20: 391-9.
241. Sackeim, H.A., Prudic, J., Devanand, D.P., et al. 1993. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839-46.
242. Sanchez-Ramos, J. R., Ortoll, R., and Paulson, G. W. 1996. Visual hallucinations associated with Parkinson disease. Arch Neurol 53: 1265-8.
243. Sands, J.R. and Harrow, M. 1995. Vulnerability to psychosis in unipolar major depression: Is premorbid functioning involved? Am J Psychiatry 152: 1009-15.
244. Santora, M. and Carey, B. 2005. Depressed? New York screens for people at risk. New York Times, April 13, p. 1, 16.
245. Sareen, J., Cox, B. J., Afifi, T. O., et al. 2005. Anxiety disorders and risk for suicidal ideation and suicide attempts. Arch Gen Psychiatry 62: 1249-57.
246. Schatzberg, A. F. and Rothschild, A.J. 1992. Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 149: 733-45.
247. Schatzberg, A. F., Posener, J.A., DeBattista, C., et al. 2000. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 157: 1095-100.
248. Schildkraut, J. J. 1965. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509-22.
249. Schmauss, M., Kapfhammer, H. P., Meyr, P., and Hoff, P. 1988. Combined MAO-inhibitor and tri-(tetra) cyclic antidepressant treatment in therapy resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 12: 523-32.
250. Schneider, K. 1920. Die schichtung des emotionalen lebens und der aufbau der depressionszustande. Zeitschrift fur die gesamte Neurologie und Psychiatrie 59: 281-6.
251. Schneider, L. S., Dagerman, K. S., and Insel, P. 2005. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA 294: 1934-43.
252. Schneider, L. S., Nelson, J. C., Clary, C. M., et al. 2003. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160: 1277-85.
253. Schneider, P. B. and Villa, J. L. 1961. Essai d'un nouveau medicament antidepressif: Le G 33040 [Opipramol]. Praxis: 1378-81.
254. Schulz, S. C. 1986. The use of low-dose neuroleptics in the treatment of ''schizo-obsessive patients.'' Am J Psychiatry 143: 1318-19.
255. Schwartz, A. C., Bradley, R. L., Sexton, M., et al. 2005. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv 56: 212-15.
256. Seach, J. 2005. How dangerous are volcanoes? http: //www.volcanolive.com/ eruption3.html, accessed November 4, 2005.
257. Shepherd, M. 1959. Evaluation of drugs in the treatment of depression. Can Psychiatr Assoc J 4: 120-8.
258. Shiraishi, H., Koizumi, J., Hori, M., et al. 1992. A computerized tomographic study in patients with delusional and non-delusional depression. Jap J Psychiatry Neurol 46: 99-105.
259. Shorter, E. 1990. Private clinics in central Europe 1850-1933. Soc Hist Med 3: 159-95.
260. Shorter, E. 1997. A history of psychiatry from the era of the asylum to the age of Prozac. New York: John Wiley.
261. Shorter, E. 2005. A historical dictionary of psychiatry. New York: Oxford University Press.
262. Signer, S. F. and Billings, R. F. 1984. Amoxapine failure-a neuroleptic property? Can J Psychiatry 29: 510-2.
263. Sigwald, J. and Bouttier, D. 1953. L'utilisation des proprietes neuroplegiques du chlorhydrate chloro-3-(dimethylamino-3'-propyl)-i0-phenothiazine en therapeutique neuro-psychiatrique. Presse Medicale 61: 607-9.
264. Sigwald, J., Bouttier, D., and Nicolas-Charles, P. 1956. Ambulatory treatment with chlorpromazine. J Clin Exp Psychopathol 17: 57-69.
265. Simeon, D., Stanley, B., Frances, A., et al. 1992. Self-mutilation in personality disorders: Psychological and biological correlates. Am J Psychiatry 149: 221-6.
266. Simpson, G. M., El Sheshai, A., Rady, A., et al. 2003. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry 64: 959-65.
267. Simpson, S., Baldwin, R. C., Jackson, A., and Burns, A. 1999. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: Comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol Psychiatry 45: 193-204.
268. Sims, J. 1799. Pathological remarks upon various kinds of alienation of mind. Memoirs Med Soc Lond 5: 372-406.
269. Slater, L. 2005. Who holds the clicker? Mother Jones (magazine), November, 30(6), pp. 62-7, 90, 92.
270. Solan, W.J., Khan, A., Avery, D.H., and Cohen, S. 1988. Psychotic and nonpsychotic depression: Comparison of response to ECT. J Clin Psychiatry 49: 97-9
271. Spiker, D.G., Dealy, R. S., Hanin, I., et al. 1986. Treating delusional depressives with amitriptyline. J Clin Psychiatry 47: 243-6.
272. Spiker, D. G., Stein, J., and Rich, C. L. 1985a. Delusional depression and electroconvulsive therapy: One year later. Convuls Ther 1: 167-72.
273. Spiker, D.G., Weiss, J. C., Dealy, R. S., et al. 1985b. The pharmacological treatment of delusional depression. Am J Psychiatry 142: 430-6.
274. Spitzer, R. L., Endicott, J., and Robins, E. 1978. Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773-82.
275. Spitzer, R. L., Endicott, J., Robins, E., et al. 1975. Preliminary report of the reliability of research diagnostic criteria applied to psychiatric case records. In Abraham Dusilovsky et al. (eds) Predictability in psychopharmacology: Preclinical and clinical correlations. New York: Raven, pp. I-47.
276. Starkstein, S. E., Jorge, R., Mizrahi, R., and Robinson, R. G. 2005. The construct of minor and major depression in Alzheimer's Disease. Am J Psychiatry 162: 2086-93.
277. Stephens, J. H. and McHugh, P. R. 1991. Characteristics and long-term follow-up of patients hospitalized for mood disorders in the Phipps Clinic, 1913-1940. J Nerv Ment Dis 179: 64-73.
278. Stevinson, C. and Ernst, E. 2004. Can St. John's wort trigger psychosis? Int J Clin Pharmacol Ther 42: 473-80.
279. Stoll, A. L., Mayer, P.V., Kolbrener, M., et al. 1994. Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 151: 1642-5.
280. Strakowski, S. M., Flaum, M., Amador, X., et al. 1996. Racial differences in the diagnosis of psychosis. Schizophrenia Res 21: 117-24.
281. Stueber, D. and Swartz, C. M. 2006. Carvedilol suppresses intractable hiccups. J Am Board Fam Med 19: 418-21.
282. Swartz, C. M. 1979. Depression with nonauditory hallucinations: Success with phenelzine. Psychosomatics 20: 286-7.
283. Swartz, C. M. 1982. Dependency of antidepressant efficacy on thyroid hormone potentiation: Case studies. J Nerv Ment Dis 170: 50-2.
284. Swartz, C. M. 1984. The justification for ECT. Behav Brain Sci 7: 37.
285. Swartz, C. M. 1989. Safety and ECT stimulus electrodes: I. Heat liberation at the electrode-to-skin interface. Convuls Ther 5: 171-5.
286. Swartz, C. M. 1995. Tardive psychopathology. Neuropsychobiology 32: 115-19.
287. Swartz, C. M. 2000. Physiological response to ECT stimulus dose. Psychiatry Res 97: 229-35.
288. Swartz, C. M. 200Ia. Misdiagnosis of schizophrenia for a patient with epilepsy. Psychiatr Serv 52: 109.
289. Swartz, C. M. 2001b Olanzapine-lithium encephalopathy. Psychosomatics 42: 370.
290. Swartz, C. M. 2002. Olanzapine-induced depression. J Pharm Technol 18: 321-3.
291. Swartz, C. M. 2003a. Antipsychotics as thought simplifiers. Psychiatric Times, January, 20(I), pp. 12-14.
292. Swartz, C. M. 2003b. Simplicity as a complication: Antipsychotics. Psychiatric Times, February, 20(2): 44-6.
293. Swartz, C. M. 2003c. Pseudomania. Psychiatric Times, June, 20, pp. 23-5.
294. Swartz, C. M. 2004a. Antipsychotic psychosis. Psychiatric Times, October, 21 (11), pp. 17-20.
295. Swartz, C. M. 2004b. Iatrogenic cancer. Psychiatric Times, September, 21(10), pp. 21-4.
296. Swartz, C. M. 2005. Aspiration and postictal agitation after electroconvulsive therapy with propofol but no succinylcholine or atropinic agent. J ECT 21: 50-1.
297. Swartz, C. M. and Galang, R. L. 2001. Adverse outcome with delay in catatonia identification in elderly patients. Am J Geriatric Psychiatry 9: 78-80.
298. Swartz, C. M. and Guadagno, G. 1998. Melancholia with onset during treatment with SSRIs. Ann Clin Psychiatry 10: 177-9.
299. Swartz, C. M. and Manly, D. T. 2000. Efficiency of the stimulus characteristics of ECT. Am J Psychiatry 157: 1504-6.
300. Swartz, C. M. and Nelson, A. I. 2005. Rational electroconvulsive therapy electrode placement. Psychiatry 2: 37-43.
301. Swartz, C. M., Morrow, V., Surles, L., and James, J.F. 2001. Long-term outcome after ECT for catatonic depression. J ECT 17: 180-3.
302. Sweeney, D., Nelson, C., Bowers, M., et al. 1978. Delusional versus non-delusional depression: Neurochemical differences. Lancet 2: 100-1.
303. Taylor, M.A., Berenbaum, S.A., Jampala, V. C., and Cloninger, C. R. 1993. Are schizophrenia and affective disorder related? Preliminary data from a family study. Am J Psychiatry 150: 278-85.
304. Taylor, M. A. and Fink, M. 2006. Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, UK: Cambridge University Press.
305. Tsuang, D. and Coryell, W. 1993. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 150: 1182-8.
306. Tsuang, M. T., Dempsey, M., and Rauscher, F. 1976. A study of atypical schizophrenia. Arch Gen Psychiatry 33: 1157-60.
307. Tsuang, M.T., Woolson, R. F., and Fleming, J. A. 1979. Long-term outcome of major psychoses. Arch Gen Psychiatry 36: 1295-304.
308. Tsuang, T., Woolson, R. F., and Fleming, J. A. 1979. Long-term outcome of major psychoses. Arch Gen Psychiatry 36: 1295-304.
309. Valenstein, E. S. 1987. Great and desperate cures: The rise and decline of psychosurgery and other radical treatments for mental illness. New York: Basic Books.
310. van den Broek, N.W., Birkenhager, T.K., Mulder, P.G., et al. 2006. Imipramine is effective in preventing relapse in electro convulsive therapy-responsive depressed inpatients with prior pharmacotheraphy treatment failure: A randomized, placebo-controlled trial. J Clin Psychiatry 67: 263-8.
311. Viguera, A. C., Baldessarini, R.J., Hegarty, J. D., et al. 1997. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54: 49-55.
312. Von Orelli, A. 1954. Der Wandel des Inhaltes der depressiven Ideen bei der reinen Melancholie, unter besonderer Beriicksichtigung des Inhaltes der Versundigungsideen. Schweizer Archiv fur Neurologie und Psychiatrie 73: 217-87.
313. Vythilingam, M., Chen, J., Bremner, J. D., et al. 2003. Psychotic depression and mortality. Am J Psychiatry 160: 574-6.
314. Wada, H., Nakajoh, K., Satoh-Nakagawa, T., et al. 2001. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 47: 271-6.
315. Walen, S. 2002. It's a funny thing about suicide: A personal experience. Br J Guid Couns 30: 415-30.
316. Weiss, E., Hummer, M., Koller, D., et al. 2000. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 20: 695-8.
317. Weissman, M.M., Prusoff, B.A., and Merikangas, K. R. 1984. Is delusional depression related to bipolar disorder? Am J Psychiatry 141: 892-3.
318. Wernicke, C. 1900. Grundriss der Psychiatrie. Leipzig: Thieme.
319. Wheatley, D. 1972. Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229-33.
320. Whitty, P., Clarke, M., McTigue, O., et al. 2005. Diagnostic stability four years after a first episode of psychosis. Psychiatr Serv 56: 1084-8.
321. Wilcox, J. A., Ramirez, A. L., and Baida-Fragoso, N. 2000. The prognostic value of thought disorder in psychotic depression. Ann Clin Psychiatry 12: 1-4.
322. Wolkowitz, O. M., Reus, V. I., Chan, T., et al. 1999. Antiglucocorticoid treatment of depression: Double-blind ketoconazole. Biol Psychiatry 45: 1070-4.
323. World Health Organization (WHO) 1967. Research in psychopharmacology: Report of a WHO Scientific Group. WHO Technical Report Series No. 371. Geneva: WHO.
324. Yassa, R., Nastase, C., Dupont, D., and Thibeau, M. 1992. Tardive dyskinesia in elderly psychiatric patients: A 5-year study. Am J Psychiatry 149: 1206-11.
325. Zanardi, R., Franchini, L., Gasperini, M., et al. 1996. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 153: 1631-3.
326. Zanardi, R., Franchini, L., Gasperini, M., et al. 1997. Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. Int Clin Psychopharmacol 12: 195-7.
327. Zanardi, R., Franchini, L., Gasperini, M., et al. 1998. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: A controlled study. J Clin Psychopharmacol 18: 441-6.
328. Zanardi, R., Franchini, L., Perez, J., et al. 1999. Dr. Zanardi and colleagues reply. Am J Psychiatry 156: 978.
329. Zanardi, R., Franchini, L., Serretti, A., et al. 2000. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot doubleblind controlled study. J Clin Psychiatry 61: 26-9.
330. Zimmerman, M. and Spitzer, R. L. 1989. Melancholia: From DSM-III to DSM-III-R. Am J Psychiatry 146: 20-8.
331. Zimmerman, M., Chelminski, I., and McDermut, W. 2002. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63: 187-93.
332. Zwanzger, P., Ella, R., Keck, M. E., Rupprecht, R., and Padberg, F. 2002. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 51: 602-3.
333. Aaron T. Beck, among possible polar depression types, the “distinction between endogenous and reactive depressions.”
334. A. T. Beck. 1967. Depression: Clinical, experimental, andtheoreticalaspects. NewYork: Hoeber/Harper & Row, p. 66.
335. David Goldberg and Peter Huxley. 1980. Mental illness in the community: The pathway to psychiatric care. London: Tavistock.
336. P[er] Bech. 1988. A review of the antidepressant properties of serotonin reuptake inhibitors. Adv Biol Psychiatry: 58-69.
337. K. Schneider. 1920. Die schichtung des emotionalen lebens und der aufbau der depressionszustaende. Zeitschriftfur die gesamte NeurolPsychiatr 59: 281-6.
338. Joe Mendels and Carl Cochrane (1968) began the revival of the endogenous-reactive split: The nosology of depression: The endogenous-reactive concept. Am] Psychiatry 124 (Suppl): 1-11.
339. I. Pilowsky et al. 1969. The classification of depression by numerical taxonomy. Br] Psychiatry 115: 937-45.
340. Michael Feinberg and Bernard J. Carroll. 1983. Separation of subtypes of depression using discriminant analysis. Affect Disord 5: 129-39.
341. Joseph J. Schildkraut, interview. 2000. The catecholamine hypothesis. In David Healy (ed.) The Psychopharmacologists, vol. 3. London: Arnold, pp. 111-34.
342. William Coryell and Ming T. Tsuang. 1982. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 39: 1181-4.
343. May 28, 1965, Antidepressant therapy, Drug and Therapeutics Bulletin 3(11): pp. 43-46.
344. H. J. Bein. 1978. Prejudices in pharmacology and pharmacotherapy: Reserpine as a model for experimental research in depression. PharmakopsychiatrieNeuropsychopharmakologie 11: 289-93
345. Gerdt Wretmark, in discussion. In Erik S. Kristiansen (ed.) 1961. Depression: Proceedings of the Scandinavian Symposium on Depression, 26-28 October 1960. Copenhagen: Munksgaard, pp. 138-9.
346. Robert Dick Gillespie. 1929. The clinical differentiation of types of depression. Guy's Hospital Reports 79: 306-44.
347. Emil Kraepelin. 1899. Psychiatrie: Ein Lehrbuch fur Studirende undAerzte, vol. 2, 6th edn. Leipzig: Barth, pp. 359-425.
348. Heinz E. Lehmann. 1971. Epidemiology of depressive disorders. In Ronald R. Fieve (ed.) Depression in the iyyo's. Amsterdam: Excerpta Medica, pp. 21-30.
349. R. Paul Penningroth, “Schizophrenia, depression, and suicide.” Psychiatry Grand Rounds, University of Iowa Hospitals and Clinics, November 16, 1976.
350. Eliot Slater. 1993. Interview. In Greg Wilkinson (ed.) Talking about psychiatry. London: Gaskell, p. 4.
351. L. C. Cook and W. Ogden. 1938. Cardiazol convulsion therapy in non-schizophrenic reaction states. Lancet 235: 885-7.
352. Edward Shorter and David Healy. In press. Shock Therapy: The History of Electroconvulsive Treatment in Mental Illness, forthcoming from Rutgers University Press, September, 2007.
353. A. D. T. Robinson. 1988. A century of delusions in South West Scotland. Br JPsychiatry 153: 163-7.
354. M. J. S. Morton, letter, 1988. Br J Psychiatry 153: 710-11.
355. P. Niskanen and K. A. Achte. 1972. Disease pictures of depressive psychoses in the decades 1880-89, 1900-09, 1930-39 and 1960-69. Psychiatria Fennica 95-100.
356. Edward Shorter. 1997. A history of psychiatry from the era of the asylum to the age of Prozac. New York: John Wiley, pp. 60-4.
357. Robert Burton. 1948/1621. The anatomy of melancholy. New York: Tudor, p. 328.
358. Felix Platter. 1963/1602. Observationes: Krankheitsbeobachtungen. Berne: Huber, pp. 75-7.
359. Joseph Guislain. 1852. Lecons orales sur les phrenopathies, ou traite theorique et pratique des maladies mentales. Ghent: Hebbelynck, pp. 105, 111, 119, 126.
360. Wilhelm Griesinger. 1964/1861. Die Pathologie und Therapie der psychischen Krankheiten, 2nd edn. reprint Amsterdam: Bonset, p. 233.
361. Theodor Tiling. 1879. Ueber Dysthymia und die offenen Curanstalten. Jahrbuch fur Psychiatrie 3: 171-86
362. Heinrich Schule. 1878. Handbuch der Geisteskrankheiten. Leipzig: Vogel, p. 439.
363. Charles Darwin. 1965/1872. The expression of the emotions in man and animals. Chicago: University of Chicago Press, pp. 176-91.
364. Georges Dumas. 1895. Les etats intellectuels dans la melancholie. Paris: Alcan p. 138.
365. E. Kraepelin. 1913. Psychiatrie: EinLehrbuchfurStudierende undArzte, 8th edn, vol. 3(2). Leipzig: Barth, pp. 1183-395
366. Emil Kraepelin. 1920. Die Erscheinungsformen des Irreseins. Zeitschrift fur die gesamte Neurologie und Psychiatrie 62: 1-29.
367. Carl Friedrich Flemming. 1844. Ueber Classification der Seelenstorungen. Allgemeine Zeitschrift fur Psychiatrie 1: 97-130
368. Thomas Arthur Ross, discussion, Edward Mapother. 1926. Discussion on Manic Depressive Psychosis. BMJ2: 872-6; Ross's comment on pp. 877-8.
369. E. Farquhar Buzzard. 1931. Treatment of nervous exhaustion. BMJ 2: 753-4.
370. Lothar B. Kalinowsky, in discussion, in Kalinowsky et al. 1944. Electric convulsive therapy of the psychoneuroses. Arch Neurol Psychiatry 52: 498-504.
371. Max Hamilton. 1974. Prediction of response to E.C.T. in depressive illness. In J[ules] Angst (ed.) Classification and prediction of outcome of depression (1973 symposium).: Schattauer, pp. 273-9.
372. L. G. Kiloh and R. F. Garside. 1963. The independence of neurotic depression and endogenous depression. Br JPsychiatry 109: 451-63.
373. M. W. P. Carney, M. Roth, and R. F. Garside. 1965. The diagnosis ofdepressive syndromes and the prediction of E.C.T. response. Br J Psychiatry 111: 659-74.
374. Carroll et al. 1980. Diagnosis of endogenous depression: Comparison of clinical, research and neuroendocrine criteria. J Affect Disord 2: 177-94.
375. G. L. Klerman, E. S. Paykel, and B. Prusoff. 1973. Antidepressant drugs and clinical psychopathology. In Jonathan Cole et al. (eds) Psychopathology and psychopharmacology. Baltimore: Johns Hopkins, conference in 1972, pp. 177-93.
376. T. A. Williams, M. M. Katz, J. A. Shield Jr. (eds) 1972. Recent advances in the psychobiology of depressive: Proceedings of a workshop sponsored by the Clinical Research Branch, Division of Extramural Research Programs, National Institute of Mental Health, hosted by the College of William and Mary in Virginia, Williamsburg, Virginia, April30-May 2, 1969. Washington, DC: GPO; DHEWPub. No. [HSM] 70-9053.
377. Samuel Guze, interview. 2000. The neo-Kraepelinian revolution. In David Healy (ed.) The psychopharmacologists, vol. 3. London: Arnold, pp. 395-414
378. Robins-Guze paper on diagnosis appeared in 1970 as Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 126: 983-7.
379. Myrna Weissman, interview. 1998. Gerald Klerman and psychopharmacology. In David Healy (ed.) The psychopharmacologists, vol. 2. London: Altman, pp. 521-42.
380. Robert Spitzer, interview. 1973. A manual for diagnosis and statistics. In David Healy (ed.) The Psychopharmacologists, vol. 3. London: Arnold, pp. 415-30.
381. Myrna Weissman, interview. 1998. Gerry Klerman and Psychopharmacology. In David Healy (ed.) The Psychopharmacologists, vol. 2, pp. 521-42.
382. E. S. Paykel, G. L. Klerman, and B. Prusoff. 1970. Treatment setting and clinical depression. Arch Gen Psychiatry 22: 11-21.
383. B. J. Carroll. 1972. Control of plasma cortisol levels in depression: Studies with the dexamethasone suppression test. In Brian Davies et al. (eds) Depressive illness: Some research studies. Springfield, IL: Thomas, pp. 87-148
384. Carroll and George C. Curtis. 1976. Neuroendocrine identification of depressed patients. Aust NZ J Psychiatry 10: 13-21
385. B. J. Carroll, G. C. Curtis, and J. Mendels. 1976. Neuroendocrine regulation in depression. Arch Gen Psychiatry 33:1039-57
386. Carroll. 1977. The hypothalamus-pituitary-adrenal axis in depression. In G. D. Burrows (ed.) Handbook of studies on depression. Amsterdam: Excerpta Medica, pp. 325-42
387. B. J. Carroll, M. Feinberg, J. F. Greden, and J. Tarika. 1981. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38: 15-22.
388. J. C. Nelson and J. M. Davis. 1997. DST studies in psychotic depression: A meta-analysis. Am J Psychiatry 154: 1497-503
389. F. Angst, H. H. Stassen, P. J. Clayton, and J. Angst. 2002. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 68: 167-81.
390. Gerald Klerman, discussion. 1966. In Philip Solomon (ed.) Psychiatric drugs: Proceedings of a research conference held in Boston. New York: Grune & Stratton p. 89.
391. C. Friedman, M. S. De Mowbray, and V. Hamilton. 1961. Imipramine (tofranil) in depressive states: A controlled trial with in-patients. JMentalSci 107: 948-53.
392. A. S. Friedman, S. Granick, H. W. Cohen, and B. Cowitz. 1966. Imipramine (tofranil) vs. placebo in hospitalized psychotic depressives. J Psychiatr Res 4: 13-36.
393. Bernard Carroll, in discussion of, Carroll. 1991. Psychopathology and neurobiology ofmanic-depressive disorders. In B. J. Carroll andJ. E. Barrett (eds) Psychopathology and the brain. New York: Raven Press, pp. 265-85.
394. William Styron. 1990. Darkness visible: A memoir of madness. New York: Random House; reprinted from an article in Vanity Fair in 1989, pp. 16-20.
395. E. S. Shneidman. 1993. Suicide as psychache. J Nerv Ment Dis 181: 145-7
396. M. T. Berlim et al. 2003. Psychache and suicidality in adult mood disordered outpatients in Brazil. Suicide Life-Threat Behav 33: 242-8
397. E. S. Shneidman. 1999. The psychological pain assessment scale. Suicide Life-Threat Behav 29: 287-91.
398. Arthur Christopher Benson. 1907. Beside still waters. London: Smith, Elder, pp. 48-50
399. Lars Vedel Kessing. 2001. Course and cognitive outcome in major affective disorder. Copenhagen: Laegeforeningens Forlag, see especially p. 27.
400. E. A. Strecker et al. 1931. The prognosis in manic-depressive psychosis. In William A. White et al. (eds) Manic-depressive psychosis: An investigation of the most recent advances.
401. Baltimore: Williams & Wilkins; Proceedings of the Association for Research in Nervous and Mental Diseases, December 29-30, 1930, pp. 471-538.
402. M. Wolfersdorf et al. 1987. Delusional depression and suicide. Acta Psychiatr Scand 76: 359-63
403. D. W. Black et al. 1988. Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders. Am JPsychiatry 145: 849-52.
404. S. P. Roose et al. 1983. Depression, delusions, and suicide. Am J Psychiatry 140: 1159-62.
405. George Winokur and Ming T. Tsuang. 1996. The natural history of mania, depression, and schizophrenia. Washington, DC: American Psychiatric Press, especially pp. 204-9
406. E. A. Strecker and B. L. Keyes. 1922. Ovarian therapy in involutional melancholia. NY MedJ 116: 30-4.
407. Alec Coppen in discussion. 1976. In B. I. Hoffbrand and G. F. B. Birdwood (eds) Biological aspects of clomipramine: Proceedings of a symposium held at Marbella, Spain, on March 12-15, 1976. Postgrad Med J 52(3): 119.
408. S. J. Kantor and A. H. Glassman. 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351-60.
409. J. D. Little et al. 2003. Right unilateral electroconvulsive therapy at six times the seizure threshold. Aust NZ J Psychiatry 37: 715-19.
410. E. Shorter. 2002. Looking backwards: A possible new path for drug discovery in psychopharmacology. Nat Rev Drug Discov 1: 1003-5.
411. Thomas Ban et al. (eds) 2002. From psychopharmacology to neuropsychopharmacology in the 1980s. Budapest: Animula, pp. 282-353.
412. Fridolin Sulser, interview. 2000. From the presynaptic neurone to the receptor to the nucleus. In David Healy (ed.) The Psychopharmacologists, vol. 3. London: Arnold, pp. 239-58.
413. A. S. Friedman et al. 1966. Imipramine (tofranil) vs. placebo in hospitalized psychotic depressives. J Psychiatr Res 4: 13-36.
414. William A. Hammond. 1871. A treatise on diseases of the nervous system. New York: Appleton, p. 381; on acute melancholia.
415. Jean Broussolle, in discussion. 1973. Psychopharmacology supplement. L'Ence-phale 62: quote on p. 60.
416. Donald Eccleston, interview. The receptor enters psychiatry (2). In David Healy (ed.) The Psychopharmacologists, vol. 3, pp. 201-12.
417. Roland Kuhn, interview. From imipramine to levoprotiline: The discovery of antidepressants. In Healy (ed.) The Psychopharmacologists, vol. 2, pp. 93-119.